Further mechanism study reveals abundant M1-type macrophages, matured DC as well as CD8+ T cells and memory T cells in tumor microenvironment after LRT therapy, demonstrating that the excellent anti-tumor efficacy of LRT therapy has been achieved by activating not only innate immune system, but also adaptive immune system. Here, CD8A is linked to neoplasm.